United Therapeutics (UTHR) Asset Utilization Ratio (2010 - 2026)

United Therapeutics (UTHR) has 17 years of Asset Utilization Ratio data on file, last reported at 0.43 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 9.59% year-over-year to 0.43; the trailing twelve-month figure through Mar 2026 stood at 0.43 (up 9.59% YoY), and the FY2025 full-year result was 0.42, up 5.44% from the prior year.
• Asset Utilization Ratio advanced to 0.43 in Q1 2026, from 0.42 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.82 in Q3 2024 to a low of 0.32 in Q1 2023.
• A 5-year average of 0.41 and a median of 0.37 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio soared 154.78% in 2024 and slumped 49.97% in 2025, its largest moves.
• Tracing UTHR's Asset Utilization Ratio over 5 years: stood at 0.33 in 2022, then increased by 0.17% to 0.33 in 2023, then surged by 138.15% to 0.78 in 2024, then plunged by 46.5% to 0.42 in 2025, then gained by 3.94% to 0.43 in 2026.
• Business Quant data shows UTHR's Asset Utilization Ratio at 0.43 in Q1 2026, 0.42 in Q4 2025, and 0.41 in Q3 2025.